Kronos Bio Inc.

NASDAQ: KRON · Real-Time Price · USD
0.88
0.01 (1.49%)
At close: Jun 20, 2025, 9:43 AM

Kronos Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
84.57M 64.33M 75.97M 339.51M
Short-Term Investments
27.85M 108.67M 162.21M 141.24M
Long-Term Investments
n/a 1.99M 9.76M 2.03M
Other Long-Term Assets
2.14M 2.6M 3.19M 112K
Receivables
n/a n/a 572K 816K
Inventory
n/a n/a -10.33M -816K
Other Current Assets
2.81M 5.78M n/a n/a
Total Current Assets
115.23M 178.78M 244.29M 347.55M
Property-Plant & Equipment
7M 29.91M 37.69M 41.78M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
9.13M 34.5M 50.65M 43.92M
Total Assets
124.36M 213.28M 294.94M 391.48M
Account Payables
2.4M 883K 5.05M 998K
Deferred Revenue
1.86M 9.58M n/a 9.06M
Short-Term Debt
3.39M 3.03M 2.35M 2.11M
Other Current Liabilities
7.59M 7.32M 7.43M 3.92M
Total Current Liabilities
15.28M 24.7M 21.49M 13.63M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 209K 1.1M
Total Long-Term Liabilities
21.51M 29.51M 28.95M 32.75M
Total Liabilities
36.78M 54.2M 50.44M 46.38M
Total Debt
24.9M 28.27M 31.09M 33.76M
Common Stock
60K 59K 57K 56K
Retained Earnings
-594.94M -508.86M -396.19M -262.98M
Comprehensive Income
9K 19K -792K -39K
Shareholders Equity
87.58M 159.08M 244.5M 345.1M
Total Investments
27.85M 110.66M 171.97M 141.24M